AI & GENOMICS ENABLED PRECISION MEDICINE, DIAGNOSTICS FOR TB- AVLOKITA TIWARI - CTO : AarogyaAI

#ai #genomics #aarogyaai #precisionmedicine #tubercolosis AI & GENOMICS ENABLED PRECISION MEDICINE, DIAGNOSTICS FOR TB Avlokita Tiwari is a bioinformatician from the University of Turku, Finland. Her expertise lies in computational biology and genomic data. Her skill set makes her computational and machine learning skills at par with her understanding of microbiology, creating a bridge between biology and the AI/ML to drive the vision of AarogyaAI. AarogyaAI is an AI-enabled SaaS that diagnoses drug-resistant tuberculosis (DR-TB) in hours instead of weeks, AarogyaAI’s drug susceptibility test ensures patients have prescribed the most effective drugs, 100X faster than the existing gold standard. AarogyaAI enables precision medicine for anti-microbial resistance in infectious disease by unlocking the power of genomics and artificial intelligence. Tuberculosis is the most lethal infectious disease, globally. Drug-resistant TB and its delayed diagnosis, exacerbate the problem. The company is backed by the largest genomics company in the world, Illumina Inc. as part of the Illumina Accelerator Program at San Francisco, USA. The Minister of Health, Govt. of India, Startup India, BIRAC amongst others in the Indian Ecosystem have recognized and awarded the innovation. https://fi.linkedin.com/in/avlokitatiwari  https://twitter.com/avlokitat  https://aarogya.ai/